ArticleExperimental & molecular medicine2015

β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.

Yong Weon Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.